← Three short discoveries on WatWat
A runner in an orange shirt on a narrow dirt trail between green shrubs
Sport

A runner’s high is a sense of well-being during endurance exercise, marked by euphoria and reduced anxiety, and endorphins have been the popular explanation for decades. Exercise releases two classes of rewarding molecules, opioids and , so the belief was never the only option. In mice, cannabinoid receptors carried the effect.

Tested in people

Blocking opioids did not stop it. In a , placebo-controlled experiment with 63 participants, failed to prevent the euphoria, the reduced anxiety or the rise in endocannabinoids after 45 minutes of running. The fraction reporting a subjective runner’s high was comparable between drug and placebo.

A runner’s high describes a sense of well-being during endurance exercise, characterized by euphoria and . It has been a widespread belief that the release of endogenous opioids such as endorphins underlies it.

Exercise, though, releases two classes of rewarding molecules: endocannabinoids and opioids. In mice, the same group had shown that core features of a runner’s high depend on cannabinoid receptors and not on opioid receptors, which set up the question for people.

The design puts the belief to the test. Sixty-three participants ran for 45 minutes at moderate intensity or walked, under the opioid receptor antagonist naltrexone or placebo, in a double-blind randomized experiment.

Running increased euphoria and decreased anxiety compared with walking, and raised plasma levels of the endocannabinoids anandamide and 2-arachidonoglycerol. Opioid blockade prevented none of it, and the fraction reporting a subjective runner’s high was comparable between groups, which makes endocannabinoids the strong candidate in humans too.

wat. With opioids blocked, the euphoria arrived on schedule.

wat wat

The explanation everybody repeats for a familiar feeling turns out to be the one the experiment rules out.

How do we know?

Siebers and colleagues compared 45 minutes of moderate-intensity treadmill running against walking, under the opioid receptor antagonist naltrexone or placebo, measuring mood, anxiety and plasma endocannabinoids.

Tested in peoplePeer-reviewed study

What is still unknown

Blocking opioid receptors leaves endocannabinoids as the strong candidate rather than the proven cause.

Learn something?

Siebers et al., Psychoneuroendocrinology· 2021· DOI 10.1016/j.psyneuen.2021.105173

Where to next

Which receptors does a runner’s high actually need?endocannabinoidsCan fifteen minutes of exercise change the kind of thinking you are capable of?exercise

Want another one worth repeating?

Start with three short discoveries. No sign-up, nothing to pick first.

Surprise me
Browse the topic libraryAbout WatWat, and how sources get checked